Display Options:
Total: 968
Antibody
Investigational
Unknown
Unknown
Anemia
Hepcidin inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 other
Antibody
Investigational
Unknown
Unknown
Ovarian Neoplasms
Epithelial cell adhesion molecule other
Antibody
Investigational
Unknown
Unknown
Unknown
Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Envelope glycoprotein B inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Plasmacytoma
HLA-DR antigens-associated invariant chain antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Selectin E inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Tumor necrosis factor receptor superfamily member 10B agonist
Antibody
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms
Cell surface A33 antigen binding agent
Antibody
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Multiple Myeloma; Neoplasms; Waldenstrom Macroglobulinemia
C-X-C chemokine receptor type 4 inhibitor
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Hematologic Neoplasms
G-protein coupled receptor family C group 5 member D binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Envelope polyprotein GP160 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Light chain aggregates inhibitor
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Interferon alpha-1/13 binding agent
Antibody
Investigational
Unknown
Unknown
Lymphoma
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Spinal Cord Injuries
Reticulon-4 inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia; Lymphoma
Unknown
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Proheparin-binding EGF-like growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia; Hyperlipidemias
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Endothelin receptor ET-B binding agent